Request Demo
Last update 15 Jul 2025
Cafusertib Hydrochloride
Last update 15 Jul 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Cafusertib, Cafusertib HCl |
Target |
Action inhibitors |
Mechanism PLK inhibitors(Polo like kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationSpecial Review Project (China) |
Login to view timeline
Related
2
Clinical Trials associated with Cafusertib HydrochlorideNCT02314884
A Phase I, Open-label, Dose-escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of Cafusertib Hydrochloride in Patients With Advanced Solid Tumors
NCT02140606
An Open Phase I Trial to Investigate the Maximum Tolerated Dose, Safety, Pharmacokinetics, and Efficacy of Intravenous Cafusertib Hydrochloride in Combination With Subcutaneous Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML)
100 Clinical Results associated with Cafusertib Hydrochloride
Login to view more data
100 Translational Medicine associated with Cafusertib Hydrochloride
Login to view more data
100 Patents (Medical) associated with Cafusertib Hydrochloride
Login to view more data
100 Deals associated with Cafusertib Hydrochloride
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Phase 1 | China | 14 Jan 2015 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 01 Nov 2014 | |
| Acute Myeloid Leukemia | Phase 1 | China | 01 May 2014 | |
| Refractory acute myeloid leukemia | Phase 1 | China | 01 May 2014 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free